Polymorphisms in genes involved in DNA repair, cell growth, oxidative stress and inflammatory response, and melanoma risk

British Journal of Dermatology

Volumn 161, Issue 1, 2009, Pages 209-212

  Gu, F ^a   Qureshi, A A ^b,c   Kraft, P ^a   Guo, Q ^a,b   Hunter, D J ^a,b   Han, J ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b CHANNING LABORATORY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

ICAM5; Melanoma; MGMT; MPO; TNF; VEGFA

Indexed keywords

CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 5; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN A;

CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CELL GROWTH; CONTROLLED STUDY; DNA POLYMORPHISM; DNA REPAIR; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; INFLAMMATION; LETTER; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MELANOMA; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; DNA MODIFICATION METHYLASES; DNA REPAIR; DNA REPAIR ENZYMES; GENETIC PREDISPOSITION TO DISEASE; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HUMANS; INFLAMMATION; INTERLEUKIN-3; MELANOMA; NERVE TISSUE PROTEINS; ODDS RATIO; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; RECOMBINANT FUSION PROTEINS; RISK FACTORS; SKIN NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 67649976891     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09219.x     Document Type: Letter

References (10)

1. Bugni JM, Han J, Tsai MS et al. Genetic association and functional studies of major polymorphic variants of MGMT. DNA Repair (Amst) 2007 6 : 1116 26.
2. Howell WM, Bateman AC, Turner SJ et al. Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma. Genes Immun 2002 3 : 229 32.
3. Ahn J, Gammon MD, Santella RM et al. Myeloperoxidase genotype, fruit and vegetable consumption, and breast cancer risk. Cancer Res 2004 64 : 7634 9.
4. Howell WM, Turner SJ, Collins A et al. Influence of TNFalpha and LTalpha single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British population. Eur J Immunogenet 2002 29 : 17 23. (Pubitemid 34146655)
5. Kammerer S, Roth RB, Reneland R et al. Large-scale association study identifies ICAM gene region as breast and prostate cancer susceptibility locus. Cancer Res 2004 64 : 8906 10.
6. Gu F, Qureshi AA, Niu T et al. Interleukin and interleukin receptor gene polymorphisms and susceptibility to melanoma. Melanoma Res 2008 18 : 330 5.
7. Han J, Colditz GA, Hunter DJ. Manganese superoxide dismutase polymorphism and risk of skin cancer (United States). Cancer Causes Control 2007 18 : 79 89. (Pubitemid 46020904)
8. Becker K, Dosch J, Gregel CM et al. Targeted expression of human O(6)-methylguanine-DNA methyltransferase (MGMT) in transgenic mice protects against tumor initiation in two-stage skin carcinogenesis. Cancer Res 1996 56 : 3244 9.
9. Hill CE, Wickliffe JK, Wolfe KJ et al. The L84F and the I143V polymorphisms in the O6-methylguanine-DNA-methyltransferase (MGMT) gene increase human sensitivity to the genotoxic effects of the tobacco-specific nitrosamine carcinogen NNK. Pharmacogenet Genomics 2005 15 : 571 8.
10. Morandini R, Boeynaems JM, Hedley SJ et al. Modulation of ICAM-1 expression by alpha-MSH in human melanoma cells and melanocytes. J Cell Physiol 1998 175 : 276 82.